Table of Contents 1 Market Overview 1.1 Fanconi Anemia Drug Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Fanconi Anemia Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Eltrombopag Olamine 1.2.3 EXG-34217 1.2.4 Fancalen 1.2.5 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Fanconi Anemia Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Overview of Global Fanconi Anemia Drug Market 1.4.1 Global Fanconi Anemia Drug Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Abeona Therapeutics Inc 2.1.1 Abeona Therapeutics Inc Details 2.1.2 Abeona Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Abeona Therapeutics Inc SWOT Analysis 2.1.4 Abeona Therapeutics Inc Product and Services 2.1.5 Abeona Therapeutics Inc Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Genethon SA 2.2.1 Genethon SA Details 2.2.2 Genethon SA Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Genethon SA SWOT Analysis 2.2.4 Genethon SA Product and Services 2.2.5 Genethon SA Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Novartis AG 2.3.1 Novartis AG Details 2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Novartis AG SWOT Analysis 2.3.4 Novartis AG Product and Services 2.3.5 Novartis AG Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Fanconi Anemia Drug Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Fanconi Anemia Drug Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Fanconi Anemia Drug Manufacturer Market Share in 2019 3.3.2 Top 6 Fanconi Anemia Drug Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Fanconi Anemia Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Fanconi Anemia Drug Sales and Market Share by Regions (2015-2020) 4.1.2 Global Fanconi Anemia Drug Revenue and Market Share by Regions (2015-2020) 4.2 North America Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 4.3 Europe Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 4.5 South America Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Fanconi Anemia Drug Sales, Revenue and Market Share by Country 5.1.1 North America Fanconi Anemia Drug Sales and Market Share by Country (2015-2020) 5.1.2 North America Fanconi Anemia Drug Revenue and Market Share by Country (2015-2020) 5.2 United States Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 5.3 Canada Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 5.4 Mexico Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Fanconi Anemia Drug Sales, Revenue and Market Share by Country 6.1.1 Europe Fanconi Anemia Drug Sales and Market Share by Country (2015-2020) 6.1.2 Europe Fanconi Anemia Drug Revenue and Market Share by Country (2015-2020) 6.2 Germany Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 6.3 UK Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 6.4 France Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 6.5 Russia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 6.6 Italy Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Fanconi Anemia Drug Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Fanconi Anemia Drug Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Fanconi Anemia Drug Revenue and Market Share by Regions (2015-2020) 7.2 China Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7.3 Japan Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7.4 Korea Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7.5 India Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 7.7 Australia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Fanconi Anemia Drug Sales, Revenue and Market Share by Country 8.1.1 South America Fanconi Anemia Drug Sales and Market Share by Country (2015-2020) 8.1.2 South America Fanconi Anemia Drug Revenue and Market Share by Country (2015-2020) 8.2 Brazil Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 8.3 Argentina Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Fanconi Anemia Drug Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Fanconi Anemia Drug Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Fanconi Anemia Drug Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 9.3 Turkey Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 9.4 Egypt Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 9.5 South Africa Fanconi Anemia Drug Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Fanconi Anemia Drug Sales and Market Share by Type (2015-2020) 10.2 Global Fanconi Anemia Drug Revenue and Market Share by Type (2015-2020) 10.3 Global Fanconi Anemia Drug Price by Type (2015-2020) 11 Global Fanconi Anemia Drug Market Segment by Application 11.1 Global Fanconi Anemia Drug Sales Market Share by Application (2015-2020) 11.2 Global Fanconi Anemia Drug Revenue Market Share by Application (2015-2020) 11.3 Global Fanconi Anemia Drug Price by Application (2015-2020) 12 Market Forecast 12.1 Global Fanconi Anemia Drug Sales, Revenue and Growth Rate (2021-2025) 12.2 Fanconi Anemia Drug Market Forecast by Regions (2021-2025) 12.2.1 North America Fanconi Anemia Drug Market Forecast (2021-2025) 12.2.2 Europe Fanconi Anemia Drug Market Forecast (2021-2025) 12.2.3 Asia-Pacific Fanconi Anemia Drug Market Forecast (2021-2025) 12.2.4 South America Fanconi Anemia Drug Market Forecast (2021-2025) 12.2.5 Middle East & Africa Fanconi Anemia Drug Market Forecast (2021-2025) 12.3 Fanconi Anemia Drug Market Forecast by Type (2021-2025) 12.3.1 Global Fanconi Anemia Drug Sales Forecast by Type (2021-2025) 12.3.2 Global Fanconi Anemia Drug Market Share Forecast by Type (2021-2025) 12.4 Fanconi Anemia Drug Market Forecast by Application (2021-2025) 12.4.1 Global Fanconi Anemia Drug Sales Forecast by Application (2021-2025) 12.4.2 Global Fanconi Anemia Drug Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Fanconi Anemia Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Fanconi Anemia Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Fanconi Anemia Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Abeona Therapeutics Inc Basic Information, Manufacturing Base and Competitors Table 8. Abeona Therapeutics Inc Fanconi Anemia Drug Major Business Table 9. Abeona Therapeutics Inc Fanconi Anemia Drug Total Revenue (USD Million) (2017-2018) Table 10. Abeona Therapeutics Inc SWOT Analysis Table 11. Abeona Therapeutics Inc Fanconi Anemia Drug Product and Services Table 12. Abeona Therapeutics Inc Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Genethon SA Basic Information, Manufacturing Base and Competitors Table 14. Genethon SA Fanconi Anemia Drug Major Business Table 15. Genethon SA Fanconi Anemia Drug Total Revenue (USD Million) (2017-2018) Table 16. Genethon SA SWOT Analysis Table 17. Genethon SA Fanconi Anemia Drug Product and Services Table 18. Genethon SA Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors Table 20. Novartis AG Fanconi Anemia Drug Major Business Table 21. Novartis AG Fanconi Anemia Drug Total Revenue (USD Million) (2017-2018) Table 22. Novartis AG SWOT Analysis Table 23. Novartis AG Fanconi Anemia Drug Product and Services Table 24. Novartis AG Fanconi Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Global Fanconi Anemia Drug Sales by Manufacturer (2018-2019) (K Pcs) Table 26. Global Fanconi Anemia Drug Revenue by Manufacturer (2018-2019) (USD Million) Table 27. Global Fanconi Anemia Drug Sales by Regions (2015-2020) (K Pcs) Table 28. Global Fanconi Anemia Drug Sales Market Share by Regions (2015-2020) Table 29. Global Fanconi Anemia Drug Revenue by Regions (2015-2020) (USD Million) Table 30. North America Fanconi Anemia Drug Sales by Countries (2015-2020) (K Pcs) Table 31. North America Fanconi Anemia Drug Sales Market Share by Countries (2015-2020) Table 32. North America Fanconi Anemia Drug Revenue by Countries (2015-2020) (USD Million) Table 33. North America Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) Table 34. Europe Fanconi Anemia Drug Sales by Countries (2015-2020) (K Pcs) Table 35. Europe Fanconi Anemia Drug Sales Market Share by Countries (2015-2020) Table 36. Europe Fanconi Anemia Drug Revenue by Countries (2015-2020) (USD Million) Table 37. Asia-Pacific Fanconi Anemia Drug Sales by Regions (2015-2020) (K Pcs) Table 38. Asia-Pacific Fanconi Anemia Drug Sales Market Share by Regions (2015-2020) Table 39. Asia-Pacific Fanconi Anemia Drug Revenue by Regions (2015-2020) (USD Million) Table 40. South America Fanconi Anemia Drug Sales by Countries (2015-2020) (K Pcs) Table 41. South America Fanconi Anemia Drug Sales Market Share by Countries (2015-2020) Table 42. South America Fanconi Anemia Drug Revenue by Countries (2015-2020) (USD Million) Table 43. South America Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) Table 44. Middle East & Africa Fanconi Anemia Drug Sales by Countries (2015-2020) (K Pcs) Table 45. Middle East & Africa Fanconi Anemia Drug Sales Market Share by Countries (2015-2020) Table 46. Middle East & Africa Fanconi Anemia Drug Revenue by Countries (2015-2020) (USD Million) Table 47. Middle East & Africa Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) Table 48. Global Fanconi Anemia Drug Sales by Type (2015-2020) (K Pcs) Table 49. Global Fanconi Anemia Drug Sales Share by Type (2015-2020) Table 50. Global Fanconi Anemia Drug Revenue by Type (2015-2020) (USD Million) Table 51. Global Fanconi Anemia Drug Revenue Share by Type (2015-2020) Table 52. Global Fanconi Anemia Drug Sales by Application (2015-2020) (K Pcs) Table 53. Global Fanconi Anemia Drug Sales Share by Application (2015-2020) Table 54. Global Fanconi Anemia Drug Sales Forecast by Regions (2021-2025) (K Pcs) Table 55. Global Fanconi Anemia Drug Market Share Forecast by Regions (2021-2025) Table 56. Global Fanconi Anemia Drug Sales Forecast by Type (2021-2025) (K Pcs) Table 57. Global Fanconi Anemia Drug Market Share Forecast by Type (2021-2025) Table 58. Global Fanconi Anemia Drug Sales Forecast by Application (2021-2025) Table 59. Global Fanconi Anemia Drug Market Share Forecast by Application (2021-2025) Table 60. Direct Channel Pros & Cons Table 61. Indirect Channel Pros & Cons Table 62. Distributors/Traders/ Dealers List List of Figures Figure 1. Fanconi Anemia Drug Picture Figure 2. Global Sales Market Share of Fanconi Anemia Drug by Type in 2019 Figure 3. Eltrombopag Olamine Picture Figure 4. EXG-34217 Picture Figure 5. Fancalen Picture Figure 6. Others Picture Figure 7. Fanconi Anemia Drug Sales Market Share by Application in 2018 Figure 8. Hospital Picture Figure 9. Clinic Picture Figure 10. Others Picture Figure 11. Global Fanconi Anemia Drug Market Status and Outlook (2015-2025) (USD Million) Figure 12. United States Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 13. Canada Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 14. Mexico Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 15. Germany Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 16. France Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 17. UK Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 18. Russia Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 19. Italy Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 20. China Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 21. Japan Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 22. Korea Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 23. India Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 24. Southeast Asia Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 25. Australia Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 26. Brazil Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 27. Egypt Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 28. Saudi Arabia Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 29. South Africa Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 30. Turkey Fanconi Anemia Drug Revenue (Value) and Growth Rate (2015-2025) Figure 31. Global Fanconi Anemia Drug Sales Market Share by Manufacturer in 2019 Figure 32. Global Fanconi Anemia Drug Revenue Market Share by Manufacturer in 2019 Figure 33. Top 3 Fanconi Anemia Drug Manufacturer (Revenue) Market Share in 2019 Figure 34. Top 6 Fanconi Anemia Drug Manufacturer (Revenue) Market Share in 2019 Figure 35. Key Manufacturer Market Share Trend Figure 36. Global Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 37. Global Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 38. Global Fanconi Anemia Drug Revenue Market Share by Regions (2015-2020) Figure 39. Global Fanconi Anemia Drug Revenue Market Share by Regions in 2018 Figure 40. North America Fanconi Anemia Drug Sales and Growth Rate (2015-2020) Figure 41. Europe Fanconi Anemia Drug Sales and Growth Rate (2015-2020) Figure 42. Asia-Pacific Fanconi Anemia Drug Sales and Growth Rate (2015-2020) Figure 43. South America Fanconi Anemia Drug Sales and Growth Rate (2015-2020) Figure 44. Middle East & Africa Fanconi Anemia Drug Sales and Growth Rate (2015-2020) Figure 45. North America Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 46. North America Fanconi Anemia Drug Sales Market Share by Countries (2015-2020) Figure 47. North America Fanconi Anemia Drug Sales Market Share by Countries in 2018 Figure 48. North America Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) (USD Million) Figure 49. North America Fanconi Anemia Drug Revenue Market Share by Countries in 2018 Figure 50. United States Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 51. Canada Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 52. Mexico Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 53. Europe Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 54. Europe Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) Figure 55. Europe Fanconi Anemia Drug Revenue Market Share by Countries in 2019 Figure 56. Germany Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 57. UK Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 58. France Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 59. Russia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 60. Italy Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 61. Asia-Pacific Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 62. Asia-Pacific Fanconi Anemia Drug Sales Market Share by Regions 2019 Figure 63. Asia-Pacific Fanconi Anemia Drug Revenue Market Share by Regions 2019 Figure 64. China Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 65. Japan Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 66. Korea Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 67. India Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 68. Southeast Asia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 69. South America Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 70. South America Fanconi Anemia Drug Sales Market Share by Countries in 2019 Figure 71. South America Fanconi Anemia Drug Revenue Market Share by Countries in 2019 Figure 72. Brazil Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 73. Argentina Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 74. Middle East and Africa Fanconi Anemia Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 75. Middle East and Africa Fanconi Anemia Drug Sales Market Share by Countries in 2019 Figure 76. Middle East and Africa Fanconi Anemia Drug Revenue Market Share by Countries (2015-2020) Figure 77. Middle East and Africa Fanconi Anemia Drug Revenue Market Share by Countries in 2019 Figure 78. Saudi Arabia Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 79. Egypt Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 80. Turkey Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 81. South Africa Fanconi Anemia Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 82. Global Fanconi Anemia Drug Sales and Growth Rate (2021-2025) (K Pcs) Figure 83. Global Fanconi Anemia Drug Revenue and Growth Rate (2021-2025) (USD Million) Figure 84. North America Sales Fanconi Anemia Drug Market Forecast (2021-2025) (K Pcs) Figure 85. Europe Sales Fanconi Anemia Drug Market Forecast (2021-2025) (K Pcs) Figure 86. Asia-Pacific Sales Fanconi Anemia Drug Market Forecast (2021-2025) (K Pcs) Figure 87. South America Sales Fanconi Anemia Drug Market Forecast (2021-2025) (K Pcs) Figure 88. Middle East & Africa Sales Fanconi Anemia Drug Market Forecast (2021-2025) (K Pcs) Figure 89. Sales Channel: Direct Channel vs Indirect Channel

Abeona Therapeutics Inc Genethon SA Novartis AG